Feedback / Questions
resiquimod sulfate (EIK1001) - Eikon Therap
https://www.businesswire.com/news/home/20251015335117/en/Eikon-Therapeutics-to-Present-New-Phase-2-Data-on-EIK1001-in-First-Line-Non-Small-Cell-Lung-Cancer-at-ESMO-2025
Oct 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next